Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06927856

The Test-to-PrEP Study

Test-to-PrEP: A Randomized Hybrid Implementation/Effectiveness Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTest-to-PrEPParticipants, called Egos, will come once to the clinic throughout the duration of the study, for up to 1 hour. During the visit, participants will receive up to 4 Test-to-PrEP Packs, which include an HIV self-test kit and HIV prevention education materials and a brief (approximately 15 minutes) training. The training includes instructions on how to initiate conversations related to HIV, HIV testing, and HIV prevention, as well as proper handling of the HIV self-test kit. Participants are asked to distribute the Test-to-PrEP Packs to Social Network Contacts (peers), called Alters.
BEHAVIORALAccess by ReferralParticipants, called Egos, will receive up to 4 Access by Referral Cards once. Participants will receive a brief (approximately 15 minutes) training. The training includes instructions on how to initiate conversations related to HIV, HIV testing, and HIV prevention, as well as proper handling of the HIV self-test kit. Participants are asked to distribute the Access by Referral Cards to Social Network Contacts (peers), also called Alters. The Referral Card can be used to order a Test-to-PrEP Pack, including the HIV self-test and HIV prevention education material, that will be mailed to an address of the Alter's choice.

Timeline

Start date
2025-04-10
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2025-04-15
Last updated
2025-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06927856. Inclusion in this directory is not an endorsement.